PIH12 COST UTILITY ANALYSIS OF HPV VACCINATION WITH BIVALENT AS04 ADJUVANT VACCINE IN SLOVAKIA AND IMPACT OF VACCINE PROTECTION DURATION ON COST-EFFECTIVENESS ENDPOINTS
Abstract
Authors
J Bielik V Foltan M Psenkova D Hroncova E Marusakova O Sadovsky